Literature DB >> 17565232

Postlaryngectomy vocal rehabilitation: assessment using a validated questionnaire in 51 patients.

R Kazi1, A Singh, J De Cordova, A Al-Mutairy, L O'Leary, C M Nutting, P Clarke, P Rhys-Evans, K J Harrington.   

Abstract

BACKGROUND: This study aimed to assess valved speech and related issues in total laryngectomy patients with the help of the validated Voice Prosthesis Questionnaire (VPQ). PATIENTS AND METHODS: We identified 61 patients who had undergone a surgical voice restoration with a valve following total laryngectomy and who were sent the VPQ by mail.
RESULTS: Fifty-one patients (37 males) completed the questionnaire giving a response rate of 83.6%. Fifty-three percent of the patients (n = 27) were fully aware of the dimensions of their valve including the length and diameter, whilst 25% (n = 13) were aware of only one of the two. There was a strong correlation between the patient's perception of tone and their gender with the tone scores significantly lower in women as compared to men (Mann-Whitney test, p = 0.04). Ten patients (19.6%) had had leakage-related issues during the previous 7 days.
CONCLUSIONS: This questionnaire provided a significant amount of valuable data. Based on our experience, we recommend the VPQ for prospective use in the serial monitoring and audit of total laryngectomy patients. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17565232     DOI: 10.1159/000103873

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  2 in total

1.  Primary tracheoesophageal puncture using carbon dioxide laser.

Authors:  Suhail Sayed; Rehan Kazi; Mohan Jagade
Journal:  Lasers Med Sci       Date:  2010-03-23       Impact factor: 3.161

2.  Social withdrawal after laryngectomy.

Authors:  Helge Danker; Dorit Wollbrück; Susanne Singer; Michael Fuchs; Elmar Brähler; Alexandra Meyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-09-16       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.